Presence of fluorescent in situ hybridization abnormalities is associated with plasma cell burden in light-chain amyloidosis
Conclusion We conclude that in AL, FISH abnormalities are associated with clonal burden. We found no impact of these markers on the type of organ involvement or 1-year survival.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Amyloidosis | Cancer & Oncology | Fish | Hematology | Stem Cell Therapy | Stem Cells | Study